JP2025506383A5 - - Google Patents
Info
- Publication number
- JP2025506383A5 JP2025506383A5 JP2024545929A JP2024545929A JP2025506383A5 JP 2025506383 A5 JP2025506383 A5 JP 2025506383A5 JP 2024545929 A JP2024545929 A JP 2024545929A JP 2024545929 A JP2024545929 A JP 2024545929A JP 2025506383 A5 JP2025506383 A5 JP 2025506383A5
- Authority
- JP
- Japan
- Prior art keywords
- unit dose
- dose form
- raav particles
- eye
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263305838P | 2022-02-02 | 2022-02-02 | |
| US63/305,838 | 2022-02-02 | ||
| US202263336191P | 2022-04-28 | 2022-04-28 | |
| US63/336,191 | 2022-04-28 | ||
| US202263336789P | 2022-04-29 | 2022-04-29 | |
| US63/336,789 | 2022-04-29 | ||
| US202263339795P | 2022-05-09 | 2022-05-09 | |
| US63/339,795 | 2022-05-09 | ||
| US202263435103P | 2022-12-23 | 2022-12-23 | |
| US63/435,103 | 2022-12-23 | ||
| PCT/US2023/061769 WO2023150566A1 (en) | 2022-02-02 | 2023-02-01 | Methods of treating ocular neovascular diseases using aav2 variants encoding aflibercept |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506383A JP2025506383A (ja) | 2025-03-11 |
| JP2025506383A5 true JP2025506383A5 (cg-RX-API-DMAC10.html) | 2026-02-25 |
Family
ID=85569710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024545929A Pending JP2025506383A (ja) | 2022-02-02 | 2023-02-01 | アフリベルセプトをコードするａａｖ２バリアントを使用して眼内血管新生疾患を処置する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250137011A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4473003A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025506383A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240145489A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023216244A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3243256A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL314455A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024009478A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023150566A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20240329A1 (es) | 2019-06-05 | 2024-02-27 | Regeneron Pharma | Dispositivos y metodos para administracion de dosis de precision |
| US12649031B2 (en) | 2021-09-08 | 2026-06-09 | Regeneron Pharmaceuticals, Inc. | Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| WO2025010334A2 (en) * | 2023-07-05 | 2025-01-09 | Adverum Biotechnologies, Inc. | Methods of treating ocular neovascular diseases using aav2 variants encoding aflibercept |
| TW202607144A (zh) * | 2024-07-16 | 2026-02-16 | 美商愛德維仁生物科技公司 | 使用編碼阿柏西普（ａｆｌｉｂｅｒｃｅｐｔ）之ａａｖ２變異體治療眼部新生血管性疾病的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3693025T3 (da) | 2011-04-22 | 2022-01-10 | Univ California | Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf |
| KR102616820B1 (ko) | 2017-03-17 | 2023-12-21 | 애드베룸 바이오테크놀로지스, 인코포레이티드 | 향상된 유전자 발현을 위한 조성물 및 방법 |
| MX2020003945A (es) * | 2017-10-18 | 2020-11-09 | Regenxbio Inc | Tratamiento de enfermedades oculares y cancer de colon metastasico con vegf-trap humano modificado post-traduccionalmente . |
| AU2021313839A1 (en) * | 2020-07-21 | 2023-03-23 | FTGEN Corp | Composition and method for treating eye diseases |
-
2023
- 2023-02-01 JP JP2024545929A patent/JP2025506383A/ja active Pending
- 2023-02-01 KR KR1020247028962A patent/KR20240145489A/ko active Pending
- 2023-02-01 AU AU2023216244A patent/AU2023216244A1/en active Pending
- 2023-02-01 IL IL314455A patent/IL314455A/en unknown
- 2023-02-01 US US18/834,864 patent/US20250137011A1/en active Pending
- 2023-02-01 CA CA3243256A patent/CA3243256A1/en active Pending
- 2023-02-01 EP EP23710583.8A patent/EP4473003A1/en active Pending
- 2023-02-01 WO PCT/US2023/061769 patent/WO2023150566A1/en not_active Ceased
-
2024
- 2024-07-31 MX MX2024009478A patent/MX2024009478A/es unknown